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Summary
Protein S is the vitamin K dcpendent cofactor of activatcd
protcin C. 1t has an important rolc m the regulation of blood
coagulation and fibrinolysis. Heieditary protein S deficiency is
associated with familial venous thrombophilia. Smce a few
patients with artenal occlusions have been rcported to be
Protein S deficient, it is speculated that hereditary protein S
deficiency may bc also a risk factor for the dcvelopmcnt of arterial
thrombosis. In a group of 37 consecutive patients with arlerial
occiusive disease presenting before the age of 45, three patients
werc found hcteiozygous for hereditaiy protein S deficiency.
None of the patients had a protein C deficiency or an antithrom-
bin III deficiency. Family investigations showed a clear associa-
tion between the hereditary deficiency and venous thrombosis,
but a rclation between the deficiency and ai terial thrombosis was
less obvious. A revicw of pievious literature on patients with
arterial thrombosis and protein S deficiency revealed that more
extensive studies arc needcd to demonstrate whcthei or not
hereditaiy piotein S deficiency is a risk factoi foi the dcvelop-
mcnt of arterial thrombosis.
Introduction
Protein S is a vitamin K depcndent plasma protein that was
discovcred in 1977 (1). Smce 1980, cvidence for its role äs an
essential cofactor of activatcd protein C has been rcported in
sevcral papcrs, wherc its importancc in the expression of both the
kinticoagulant and the profibrinolytic activity of activatcd pro-
tcin C was demonstrated (2-4). After the first casc leports of
patients with familial venous thiombophilia due to hereditary
protein C deficiency (5-7), it was pointed out in subscquent
papers that this syndromc could also be causcd by hereditary
protein S deticiency (8-10).
Moreover, some invcstigators have reported the presence of
hereditaiy protcin S deficiency in young patients with manifesta-
tions of ai terial thrombosis (11-18).
To comparc the prcvalence of piotein S deficiency in patients
with ai terial thrombosis with the reported prevalence in patients
with venous thrombophilia, we screencd 37 consecutive patients
with arterial occlusion presenting before the age of 45. In the
familics of the patients with a hereditaiy deficiency we invcsti-
gated whether the defect was associated with Symptoms of arterial
thrombosis, venous thrombosis or both. In this papcr we prcsent
the icsults of thcse studies and discuss possible lelations between
piotein S deficiency and the occurrencc of venous and arterial
thrombosis.
Coirespondcncc to Di C F Allaalt, Haemostasis and Thiombosis
Rcscaich Unit, Umvcisity Hospital Leiden, Building t, C2-R, PO Box
9600, 2300 RC Leiden, The Ncthcilands
Patients and Methods
Wc camed out a study m the department of vasculai surgeiy in the
Umveisity Hospital Leiden, with the puipose to detect disoiders m the
icgulation of coagulation and hbrinolysis, fat raetabolism and methionm
metabohsm m patients with aitenal occlusions in the lowci cxtiemities
picscntmg before the age of 45 Patients with vascular occlusions caused
by tiauma, pophtcal cntrapmcnt 01 adventitial cystic disease weie
excludcd ftom the study Thirty-sevcn consecutive patients who had been
ticatcd at the department of vasculai suigeiy between the years 1978 and
1987 weic invitcd to the outpatient chnic and all agieed to paiticipatc in
the study The diagnosis was based on the patient's histoiy, the physical
exammation, the Dopplei picssuie mdices at the ankle levcl, and if
available the angiogiaphic findmgs When surgeiy was pcifoimed, the
mtia-opcrativc obseivations and the histologic exammation of the spcci-
mcn obtamcd dunng suigeiy confirmed the diagnosis The lesions wcre
equally distnbutcd between aoitic-ihac and femoio-distal rcgions, äs
could be seen on the angiograms
All laboiatoiy methods and outcomcs of the completc study have been
published m dctail (19) To detect an isolated protein S deficiency venous
blood was collected in 1/10 volume of 0 11 M tusodium citrate Platclet
free plasma was obtamed by centntugmg the platclct poor plasma for
30 mm at 20,000 x g at 4° C Total piotein S antigcn was mcasured with
an EL1SA, iccently dcvcloppcd in oui laboiatoiy (20) and based on the
same pimciples earhei applicd in the immunoiadiometnc assay (21)
Piotein C antigcn, factoi II antigcn, and tactor X antigen weie mcasured
by electio-immunoassay (6) Fiom the thiec patients wheie a Iow plasma
levcl piotcm S was found (scc below) a second plasma sample was
obtamcd to conlnm the iirst lesults The results of the second analysis
confnmed that all thiec patients had an isolated protcin S deficiency The
diagnosis was based on the followmg cntciia a total protcin S-antigcn
levcl below the lowci limit of the noimal ränge found in healthy contiols
(67—125%, n = 45) 01, for patients on oial anticoagulanl therapy, a total
protein S-antigcn Icvel below the lowei limit of the lange found in a
icfcicnce gioup ot patients icccivmg coumann thciapy (33-74%,
n = 93) Othei vitamin K-dcpcndent factoi s had to be withm the normal
lange äs found m the contiols with 01 without coumann theiapy (21)
Subsequently, all available iclatives ot the probands wcrc mvestigatcd,
usmg the samc methods and cntciia In family A and C, with a positive
family history toi arteual thrombosis, cholcsteiol levels in serum werc
measuicd äs well
The mcdical histoiy of all paiticipatmg family membcrs was taken and
mfoimation about theu deccased iclatives was also obtamed Wc
classified all tamily membcis into thiec gioups accordmg to the piobabil-
ity lhat they weic hcteiozygous for heieditary piotein S deficiency This
classification was based on the laboiatoiy results of the paiticipatmg
family mcmbeis and the position m thc pedigrec of those who couldn't
paiticipate Individuais with a documented piotein S deficiency have a
100% piobability to be hetciozygous, those with normal protein S levels
have a 0% piobability When thcir protein S levels aic unknown, cach
paient of a known hetciozygotc has a 50% piobability to be hcteiozygous
foi thc deficiency äs well, aunts and uncles have a 25% probabihty and so
on Gioup l includes tamily membcrs with a less than 12 5% probabihty
to be helciozygous, gioup 2 icpresents all of those with a probabihty
between 12.5% and 50%, and mdividuals with a 100% piobability to bc
hcteiozygous aic m gioup 3 Wc diew up hfe tablcs foi the occurrence
of venous thiombosis and aitenal thiombosis.
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Fig. l Pedigrcc of family A. Π = male; O = fcmalc; O = sex unknown;
l" l = history of artcrial thrombosis; ' = history of vcnous throm-
bocmbolism; 1Ί = dcccased; l = invcstigatcd; 01 = hctcrozygous for
hcrcditary protcin S deficiency; \ = propositus
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Fig. 2 Pedigrcc of family B. Symbols: see Fig. l
Results
Case Reports and Family Results
In the group of 37 consecutive patients with peripheral arterial
occlusions presenting before the age of 45, three patients (8%)
were protein S dcficicnt. Family investigations were then carried
out. The rcsults of the measurement of protein S, protein C,
factor II and factor X antigen have been listed in Tables l, 2 and
3. The medical historics of the threc patients and the results of the
fcfamily studies are the following:
Patient A (III-2 in Fig. 1) had the first complaints of claudica-
tion at the age of 39, which were slowly progressive in the
following year. He smokcd about 10 cigarettes a day, was healthy,
and hypertcnsion and diabetes mellitus were absent. Angiography
showed an occlusion of the right superficial femoral artery and a
venous femoropopliteal bypass was pcrformed. Five years later he
was frce of Symptoms with normal Doppier ankle/arm indices.
When he entered the study, a serum cholesterol level was
measured of 8.9 mmol/1. Further investigations showed that he
had a type Ilb hypcrlipoproteinemia. In his family (family A,
Fig. 1) II-5 and I-la had dicd of a myocardial infarction before the
age of 50. II-6 had suffered from recurrent superficial thrombo-
phlebitis, with the first episode after dclivery at the age of 35. She
survivcd two myocardial infarctions at 68 and 69 years of age, but
died recently, presumably of a third myocardial infarction. I-2a
was said to have had deep venous thrombosis after childbirth. II-8
who has non-insulin depcndent diabetes mellitus, has recently
suffered from an arterial occlusion in a leg. He could not
participate in the study. No other family members had suffered
episodcs of venous thromboembolism or arterial occlusion. Only
the asymptomatic sister of the propositus (ΠΙ-3) was found to be
heterozygous for protein S deficiency. In this family serum
cholesterol levels were measured. The serum cholesterol level was
high (9.6 mmol/1) in II-6, but normal (i. e. less than 6.5 mmol/1) in
the other participants.
Patient B (II-2 in Fig. 2) had her first Symptoms of claudication
at the age of 39. She smoked 15 cigarettes a day and was treated
for hypertension. Her medical history further included pulmonary
embolisms of unknown origin at the age of 35 and seropositive
rheumatoid arthritis since age 26. She had had several surgical
operations without complications. Angiography showed an occlu-
sion of the right, and a significant Stenosis of the left common iliac
artery. An aortobifemoral bypass was implanted and she stopped
Table l Family A: results of laboratory studies
Pedigrcc
numbcr
II-5a
II-6
111-2*
III-3
IV-3
IV-4
IV-5
IV-6
Sex
F
F
M
F
F
M
F
F
Age
(ycars)
70
76
44
35
20
18
12
8
PS-ag
116
97
30
65
87
106
114
87
PC-ag
118
154
54
117
123
79
87
87
Fll-ag
123
123
54
138
111
118
102
108
FX-ag OAC def
118
154
43 + +
152 - +
140
106
102
102
F = female, M = male; OAC = oral anticoagulation; def = protcin S
dcficient; * propositus.
Table 2 Family B: rcsults of laboratory studies
Pedigrec
number
1-6
II-l
II-2*
II-3
III-l
ΙΠ-2
III-3
III-4
Sex
M
M
F
M
F
M
M
M
Age
(years)
64
45
43
39
19
17
20
17
PS-ag
102
11
66
27
86
45
55
49
PC-ag
200
33
100
74
82
87
115
110
FTI-ag
138
32
145
63
74
120
92
92
FX-ag OAC def
118
37 + +
120 - +
45 + +
60
80 - +
80 - +
95 - +
F = female, M = Male; OAC = oral anticoagulation; def = protein S
deficicnt; * the propositus.
Table 3 Family C: results of laboratory studies
Pedigrec
numbcr
II-6
II-9
III-l
III-2
III-3
III-5
1II-6
III-8
III-9
111-12
111-13
111-14
111-15
111-16*
111-17
111-18
IV-26
IV-27
Sex
M
M
M
M
F
F
M
M
M
M
F
F
M
M
F
M
M
F
Age
(ycars)
62
72
61
47
45
51
41
41
58
51
36
34
29
45
32
21
11
7
PS-ag
134
79
126
127
103
117
111
101
118
127
111
95
96
19
93
96
35
36
PC-ag
94
48
94
108
120
125
125
102
120
108
108
108
96
68
100
84
75
75
Fll-ag
128
67
87
138
103
132
96
96
102
120
128
96
103
47
110
90
71
81
FX-ag OAC def
118
61 + -
94
123
130
123
118
103
114
168
123
130
123
29 + +
118
104
77 - +
81 - +
F = female, M = male; OAC = oral anticoagulation; def = protcin S
dcficicnt; * propositus.
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Pedigiec of family C Symbols scc Fig l
smokmg Foui years later she was frec of Symptoms and the
^Dopple! ankle/aim indices wcre normal When she entered the
study, a serum cholesteiol level of 6 2 mmol/1 was measuied
In her family (family B, Fig 2), 1-2 was repoitcd to have
suffeied fiom a deep venous thrombosis at the age of 19 after
immobihzation dunng a pneumoma Only one of his brotheis
(1-6) was able to participate m the study At the age of 62, this
man had icceived anticoagulant therapy foi an axillary vein
thrombosis followmg abdominal surgery Il-f and II-3 had
suffered from spontaneous deep venous thiombosis at the age of
30 None of the family membeis had had Symptoms of artenal
occlusive disease II-l and 11-3 weie found to be hcterozygous foi
protcin S deficiency, äs wcie III 3, III-4 and III-2
Patient C (111-16 in Fig 3) had claudication when he was
35 yeais of age Hc smoked 25 cigarettes a day and had always
been hcalthy before A few months eaihei he had suffeied from a
deep venous thiombosis in the left leg aftei immobilization for
what was thought to be a tendimtis, and he leceivcd coumann
theiapy smce Angiogiaphy showed an occlusion of the aorta with
an extensive collateral circulation An aoitobifemoial bypass was
performed and f year later hc was ftee of Symptoms At the Start
of the study a serum cholesterol level of 8 l mmol/1 was mea-
ksured In his family (family C, Fig 3) 11-10 had suffered fiom
pulmonary embolisms m the year before he died of lungcancer
He also had had a myocaidial mfarction before the age of 65 Of
his gencration, only two relatives were still alivc at the time of the
mvcstigation The first was II 6, who had a myocardial mtaiction
at the age of 60 One month aftei the study he died after a second
mfaiction, aged 62 The second was II-9, who at 56 refused to
icccive surgeiy foi artenal occlusive disease in a leg and who had
a myocardial mfaiction at the age of 70, while on oral anticoagu-
lant theiapy II-l died of myocardial mfaiction at age 66 II-2
suffeied from a stroke at the age of 42 and died followmg vascular
surgery foi an acute aitcnal occlusion in a leg at the age of 54 II-4
suffered a fatal stroke at age 50 Hei son (ΙΠ-4) died of a heait
attack dunng a soccermatch, 33 yeais old II-7 had had non-
insuhn dcpendent diabetes melhtus, he died in his sleep at the age
of 66, aftei havmg chestpam the previous cvemng Some ycars
caiher a medical cxammation had revealed that hc had suffered a
silent myocaidial mfaiction II 8 had a heart attack at the age of
65 His cldcst son (ΠΙ-9) suffered from an occlusion of the left
aitcua cciebn mcdia at age 57 111-12 received surgery because of
an aitenal occlusion m the leg when he was 20 yeais old He was
fice of Symptoms smce Of all family mcmbers participating, only
two children of the piopositus (IV 26 and IV-27) weie found to bc
heterozygous foi protein S deficiency The serum cholesterol
100
β ϋ ^ - j^j —g
10 20 30 40 50
age (years}
70 80
Fig 4 Litctablc venous thrombocmbohsm thiombosis hee surviva]
iclated to the piobabihty of betng heteiozygous foi heieditaiy protein S
deficiency, -D- 0 to 12 5% piobabihty to bc heteiozygous (n = 52),
-Δ- 12 5 to 50% piobabihty (n = 25), -O- 100% piobabihty (n = 12,
piobands mcluded)
100 t*·
10 20 30 40 50
age (years)
70 80
Fig 5 Lifetablc aitcnal thiombosis thrombosis fiee suivival rclated to
the piobabihty ot bcmg hcterozygous foi heieditaiy piotcm S deficiency,
-D- 0 to 12 5% piobabihty to bc heteiozygous (n = 52) -Δ- 12 5 to
50% piobabihty (n = 25) -O- 100% piobabihty (n = 9, piobands ex-
cludcd)
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levels in the family were under 6.5 mmol/1, cxcept in II-9
(6.7 mmol/1), III-5 (6.6 mmol/1), 111-13 (7.8 mmol/1) and IV-9
(7.1 mmol/1).
After dividing all family mcmbers into three groups according
to the probability that they were heterozygous for hereditary
protein S deficiency we drew up life tables with regard to the
occurrence of venous and arterial thrombosic events. After the
age of 40, venous thrombotic events occurred more often in
heterozygotes than in persons with a 50% or Icss probability of
being heterozygous for the deficiency (Fig. 4). The occurrence of
arterial thrombosis did not incrcase with the probability of having
the deficiency (Fig. 5).
Discussion
Since 1980 the role of protein S äs cofactor of activated
protein C has been reported in several papcrs (2-4). Activated
protein C inhibits the blood coagulation cascadc by inactivating
factors Va and Villa (22, 23). It accclerates clot lysis äs well (4,
24). Protein S is an esscntial cofactor for the expression of both
«perties of protein C (3, 4). In plasma protein S is present in a; form and bound in a complex with C4b-binding protein; only
the free from acts äs a cofactor for activated protein C (25).
In several publications the association between familial throm-
bophilia and hereditary protein C deficiency was reported (5-7,
26, 27). The same association for hereditary protein S deficiency
and venous thrombophilia was demonstrated (8-10). It was
cstablished that, in families with venous thrombophilia and
protein S deficiency, heterozygotes for the deficiency tend to
develop venous thrombosis more often and at a younger age than
non-deficient family members (10).
In the literature several patients with arterial thrombosis and
protein S deficiency have been reported (8-18). The type of study
and the crilcria on which the diagnosis protein S deficiency was
based showed considerable Variation.
Schwarz et al. (9), Coller et al. (11), Mannucci et al. (12),
Israels et al. (13) and Girolami et al. (14) all presented a case of a
patient with arterial thrombosis at a young age with a hereditary
protein S deficiency. No Information was given on the selection
procedurc of the probands. The diagnosis was based on the
finding of low total protein S levels (9, 12, 14) or on the presence
«ow free protein S levels with normal total protein S levels (11,. Family investigations revealed heterozygous relatives, somc
of whom had suffered from venous thromboembolic events (9, 11,
12, 14). No Information was given about a possiblc family history
of arterial thrombosis.
Von Feiten et al. (15), Thommcn et al. (16), Schäfer et al. (17),
and Chancellor (28) screened groups of patients with arterial
thrombosis for protein S deficiency and othcr deficiencies. The
inclusion criteria of these studies were not always clearly defined.
The patients initially reported by von Feiten et al. were included
in the 33 patients with arterial cerebral thrombosis studied by
Schäfer et al. In total ninc patients were reported to have a
protein S deficiency, defined äs low total protein S levels with low
free protein S levels, which was familial in four cases. Four other
patients had low free protein S levels but normal total protein S
levels, and this type of deficiency was a found to be familial in one
casc. Thommen et al. (16) investigated scven patients with
arterial thrombosis, and reported one patient with low free
protein S levels and low (calculated) total protein S levels, a
phenotype also found in an asymptomatic sister of the patient.
Other patients were described with low free protein S levels and
various outcomes in the calculation of total protein S and the
mcasurement of C4b-BP-bound protein S, but in none of those
cases a hereditary dcfect was proven. In the thrce reports the
Information about the occurrence of venous and arterial throm-
bosis in the families is incomplete. Chancellor et al. (28)
measured total and free protein S antigen levels and found no
protein S deficiencies in a study in 38 consecutive patients with
unexplained non-hemorrhagic cerebral infarctions.
Recently, Sie et al. (18) reported on six patients with protein S
deficiency and arterial thrombosis at a young age, identified
among 23 symptomatic heterozygotes from 17 families. The
diagnosis was based on a low total protein S level, or on a normal
total protein S with a low free protein S antigen level. It is not
clcar on which criteria the families had been selected and the total
numbcr of heterozygotes in these families is unknown. In three of
the six patients a hereditary deficiency was not proven or not
reported. A positive family history for venous thrombosis was
present in three cases, familial arterial thrombosis was not
reported.
Only one report on hereditary protein S deficiency in patients
selected on the basis of venous thrombophilia gives Information
about the occurrence of arterial thrombosis in the families
studied: Engesser et al. (10) interviewed 72 heterozygotes in 12
protein S deficient families. Twenty-five of these persons were
more than 50 years old at the time of the interview (personal
communication) and none of them had had Symptoms of arterial
disease.
We carried out a study in the department of vascular surgery in
37 consecutive patients with symptomatic arterial occlusive dis-
ease before the age of 45. Three proved to be heterozygous for
hereditary protein S deficiency (8%). The prevalence of hered-
itary protein S deficiency in the gcneral population is unknown, in
patients with venous thrombophilia it is reported to be between 2
and 8% (29-31). The fact that we find a similar prevalence in the
group of patients with arterial thrombosis suggests that the defect
may be a risk factor for arterial thrombosis äs it is for venous
thrombosis. However, since the defect is hereditary, an associa-
tion between deficiency and Symptoms should then also be
evident in family studies.
To investigate whether or not a relation between protein S
deficiency and Symptoms of arterial thrombosis was present in the
families of the three patients with the deficiency, we divided all
family members into three groups according to the probability
that they were heterozygous. Life table analysis demonstrated a
clear relation between the occurrence of venous thrombosis and a
heterozygous state for hereditary protein S deficiency (Fig. 4).
This corroborates previous findings in a study of 12 families with
hereditary protein S deficiency (10). The result is all the more of
interest since, in contrast to the previous study, venous throm-
bophilia was not a selection criterion in our study.
On the other hand, the occurrence of arterial thrombosis did
not incrcase with the probability of having the deficiency (Fig. 5).
However, in this exercise we did not include the three probands
since their Symptoms were the reason why they were included in
the study. Group 3 thus consists of only nine individuals with a
100% probability to be heterozygous. The fact that they were on
average younger (mean age 26.7 years, ränge 8 to 52 years) than
the members in the other two groups (mean age 37.1 years, ränge
0 to 78 years) might cxplain why no correlation between protein S
deficiency and arterial thrombosis was found.
None of the patients in our study had a deficiency of protein C
or antithrombin III. This suggests that there might bc a special
relation between protein S deficiency and the development of
arterial thrombi. A direct effect may bc possible, äs both
endothelial cells and platelets are sites of protein S synthesis and
action in vivo (32). A high serum cholesterol may be a potentiat-
ing factor.
We conclude that hereditary protein S deficiency is relatively
frequent among patients with arterial occlusive disease. The
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defect is a nsk factor for the development of venous thrombosis,
and it seems to be associated with the occurrence of artenal
thrombosis äs well An open eye for this possibility m the
approach of mdividual patients, and more extensive family and
epidemiologic studies may help to determme whethei or not
hereditary protem S deficiency is mdeed a nsk factor for the
development of artenal occlusive disease and thrombosis
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